Explore the hidden economic burdens of eye cancer in India and the urgent need for awareness, access, and specialized care.

Capturing Unicorns: Targeting Cancers With TP53 Mutations, RAS Alterations Beyond G12C, and MTAP Loss—No Target Is Out of the Realm of Possibility Bispecific antibodies (bsAbs) have emerged as a novel ...

University of Pennsylvania Perelman School of Medicine and Yale University School of Medicine, along with other collaborators, report that lung adenocarcinoma can engage nerve pathways that link the ...

The potential of microrobots is enormous. These miniature objects can be designed to carry out actions within the body, such as sensing biomarkers, manipulating objects like blood clots, or delivering ...

Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer. Notoriously aggressive and difficult to treat, pancreatic cancer is rarely ...

Cancer and Alzheimer's are two of the most common chronic diseases associated with aging. For years, doctors have known about a curious aspect of these two conditions: people who survive cancers are ...

Design Data analysis of this population-based cohort study was conducted from September to November 2024. Setting The data are based on 17 Surveillance, Epidemiology and End Results (SEER) registries ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug injected directly into the tumor is absorbed by macrophages, prompting them ...

Clinical photographs of sebaceous carcinomas. (A) Sebaceous carcinoma in the lower eyelid. (B) Sebaceous carcinoma in the ear pinna. (C) Sebaceous carcinoma in the upper lip of a patient with MTS. The ...

Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable to perform their roles properly due to suppression by the tumor. A KAIST ...

Megan Barnet receives funding from Boehringer Ingelheim, Takeda Pharmaceuticals, and government-funded grants including the NHMRC. Sarah Sasson does not work for, consult, own shares in or receive ...

With four FDA-approved oncology indications and trials exploring new uses, tumor treating fields are emerging as a promising therapeutic option for certain patients with cancer. While using ...